Fundraising FoxOxeia Biopharmaceuticals
San Diego, US · Founded 2014
Find your way into Oxeia Biopharmaceuticals
212 people in our graph can introduce you to the Oxeia Biopharmaceuticals team.
Sign up to see every warm intro you have to Oxeia Biopharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Oxeia Biopharmaceuticals team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Oxeia Biopharma develops therapeutics for concussion and brain injury treatment, focusing on moving beyond conservative management toward active clinical interventions.
Founders & leadership
Oxeia Biopharmaceuticals was founded in 2014 by Kartik Shah and Amit Munshi.
KS
Kartik ShahCo-founder
AM
Amit MunshiCo-founder
MW
Michael WyandCEOHe has held executive management and corporate officer roles with P&L responsibility at both private and public companies, with experience in clinical development, regulatory affairs, manufacturing, and international partnership management across multiple regions.
Funding
SEC filings, press & company announcements$310K disclosed across 1 of 2 rounds · 2014–2026
- Undisclosed amountRegulation Crowdfunding (Reg CF) campaignAug 2026Source ↗
▶$310KraisedJun 2014 · 5 investors · PharmaceuticalsRule 506(b)
▶$310KraisedJun 2014 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kartik ShahExecutive Officer, Director, Promoter
- Amit MunshiExecutive Officer, Director, Promoter
- Offering amount
- $310K
- Amount sold
- $310K
- First sale
- Jun 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Oxeia Biopharmaceuticals do?
- Oxeia Biopharma develops therapeutics for concussion and brain injury treatment, focusing on moving beyond conservative management toward active clinical interventions.
- Who founded Oxeia Biopharmaceuticals?
- Oxeia Biopharmaceuticals was founded by Kartik Shah, Amit Munshi in 2014.
- How much funding has Oxeia Biopharmaceuticals raised?
- Oxeia Biopharmaceuticals has disclosed $310K raised across 1 of its 2 known rounds.
- Where is Oxeia Biopharmaceuticals headquartered?
- Oxeia Biopharmaceuticals is headquartered in San Diego, US.